SLC1A2 and Parkinson disease: Vitamin C acts as a neuroprotective agent by promoting astrocyte GLT-1 expression, reducing glutamate aggregation, and attenuating excitatory damage in Parkinson’s disease (PD)(Zeng et al., 2022).